Osimertinib-Savolitinib in Advanced NSCLC after Progression during EGFR-TKI Therapy. (nejm.org)

Authors: Lu S … Okuma Y Journal: New England Journal of Medicine Published: 2026-10-25 DOI: https://doi.org/10.1056/NEJMoa2611335